gala glp-1 Gala Health | GLP-1 meal
Description
National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)
New data reveals that sales growth of semaglutide and GLP-1 therapies slowed...
Stock screener for investors and traders, financial visualizations.
FDA Enforcement Actions and Safety Concerns In September 2025, the FDA issued over 50 warning letters to compounders marketing GLP-1 products as generic equivalents to FDA-approved drugs
Ozempic, Wegovy and Mounjaro accounted for nearly $4-billion in sales at retail pharmacies in 2025, according to IQVIA Canada
The three active ingredients work through different pathways to support overall metabolic wellness
